MyFinsight
Home
About
Contact
antx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, ANTX has $67,235K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
67,235
75,825
Total stockholders' equity
60,377
68,842
Total liabilities and stockholders' equity
67,235
75,825
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$2,095K
Short-term investments
$43,918K
Cash and cash
equivalents
$18,003K
Long-term investments
$3,219K
Total current assets
$64,016K
Total assets
$67,235K
Total liabilities and
stockholders' equity
$67,235K
Total stockholders'
equity
$60,377K
Total liabilities
$6,858K
Accumulated deficit
-$232,240K
Accumulated other
comprehensive gain
$64K
Additional paid-in capital
$292,553K
Other current
liabilities
$183K
Accrued liabilities
$2,705K
Accrued compensation
$1,744K
Accounts payable
$2,226K
Subscribe for Financial Insights
AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. (ANTX)